Works matching IS 1007385X AND DT 2024 AND VI 31 AND IP 5

Results: 15

Establishment of an in vitro cytotoxicity evaluation model for BCMA CAR-T cells based on BCMA mutants.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 493, doi. 10.3872/j.issn.1007-385x.2024.05.009

By:

ZHANG Xiaoxue;
HUA Jinghan;
HOU Rui;
LIU Dan;
SHI Ming;
CAO Jiang

Publication type:

Article

PD-1 antibody versus high-dose interferon as post-operation adjuvant therapy for stage IIB-IIID melanoma patients: a retrospective cohort study.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 484, doi. 10.3872/j.issn.1007-385x.2024.05.008

By:

ZHENG Kelin;
ZHAO Lianjun;
REN Yu;
SUN Qi;
ZOU Zhengyun

Publication type:

Article

Effect of KIF2C on the malignant biological behavior of hepatocellular carcinoma cells and angiogenesis of human umbilical vein endothelial cells.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 477, doi. 10.3872/j.issn.1007-385x.2024.05.007

By:

AN Haiying;
TU Jiancheng

Publication type:

Article

Combined application of berberine and XAV939 inhibits the migration and apoptosis of osteosarcoma cells MG-63.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 469, doi. 10.3872/j.issn.1007-385x.2024.05.006

By:

WU Haoyue;
KANG Bing;
TIAN Zhimin;
ZHANG Haoqiang;
LI Xusheng

Publication type:

Article

Research progress of Denosumab combined with immune checkpoint inhibitors in patients with bone metastasis of non-small cell lung cancer.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 528, doi. 10.3872/j.issn.1007-385x.2024.05.014
Publication type:: Article

Allergic shock in children with neuroblastoma caused by naxitamab: a case report and literature review.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 535, doi. 10.3872/j.issn.1007-385x.2024.05.015
Publication type:: Article

Application of CRISPR/Cas9 gene editing technology in the research of precision oncology.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 519, doi. 10.3872/j.issn.1007-385x.2024.05.013
Publication type:: Article

Research progress on the effects of 5-LOX and its inhibitors on tumors.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 514, doi. 10.3872/j.issn.1007-385x.2024.05.012
Publication type:: Article

The role of neutrophils in tumor development and immunotherapy.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 507, doi. 10.3872/j.issn.1007-385x.2024.05.011
Publication type:: Article

Research progress in the role of eosinophil in immunotherapy of lung cancer.

Published in:: Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 501, doi. 10.3872/j.issn.1007-385x.2024.05.010
Publication type:: Article

The role of KRT6A in regulating the biological behavior of pancreatic ductal adenocarcinoma PANC1 cells and its role as a target for diagnosis and prognosis.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 462, doi. 10.3872/j.issn.1007-385x.2024.05.005

By:

WANG Haoze;
YANG Xuan;
CHEN Xinyuan;
GU Yan

Publication type:

Article

Effects of vesicular stomatitis virus on anti-tumour immunity, growth of xenografts, and lung metastasis in mouse mammary carcinoma 4T1 cells tumor-bearing mice.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 452, doi. 10.3872/j.issn.1007-385x.2024.05.004

By:

LI Yuqian;
XU Qingsheng;
WEI Hong;
WANG Hao;
WANG Shuoshi;
JIANG Lina;
YUAN Xinyi

Publication type:

Article

Ginsenoside Rb1 promotes oxeiptosis in hepatocellular carcinoma HepG2 cells through KEAP1/PGAM5/AIFM1 pathway.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 445, doi. 10.3872/j.issn.1007-385x.2024.05.003

By:

ZHU Jingxuan;
SONG Nan;
YANG Ying;
WANG Jie;
GAO Hao;
JIA Lianqun

Publication type:

Article

Decanoic acid activates CD8<sup>+</sup> T cells and enhances their anti-tumor immune responses.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 437, doi. 10.3872/j.issn.1007-385x.2024.05.002

By:

ZHANG Chong;
JIN Haizhen;
ZHOU Chun;
HU Huihui;
WANG Juan;
WANG Qinlan

Publication type:

Article

Innate lymphoid cells and cancer immunoediting.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 5, p. 429, doi. 10.3872/j.issn.1007-385x.2024.05.001

By:

WU Kefu;
ZHENG Guoguang;
MA Xiaotong;
SONG Yuhua

Publication type:

Article